Polly Burbidge - Concepedia

Author

Polly Burbidge

University College London

Also Known As

Burbidge, P, P Burbidge, P. Burbidge, Polly Burbidge

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University College London Public Health England University of Oxford Great Ormond Street Hospital Johns Hopkins University

About

Polly Burbidge is an author at University College London specializing in vaccination, medicine, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	591
2	Immunology	3	3	53
3	Epidemiology	1	1	538
4	Microbiology	1	1	19
5	Humoral Immunity	1	1	23

Polly Burbidge

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study Nick Andrews, Pauline A. Waight, Polly Burbidge, The Lancet Infectious Diseases VaccinationVaccine SafetyPreventive MedicineVaccine EfficacyInfection Control	2014	538
Antibody Responses After Primary Immunization in Infants Born to Women Receiving a Pertussis-containing Vaccine During Pregnancy: Single Arm Observational Study With a Historical Comparator Shamez Ladhani, Nick Andrews, Jo Southern, Clinical Infectious Diseases	2015	173
Immunogenicity and Boosting After a Reduced Number of Doses of a Pneumococcal Conjugate Vaccine in Infants and Toddlers David Goldblatt, Jo Southern, Lindsey Ashton, The Pediatric Infectious Disease Journal	2006	164
The Immunogenicity of 7‐Valent Pneumococcal Conjugate Vaccine versus 23‐Valent Polysaccharide Vaccine in Adults Aged 50–80 Years David Goldblatt, Jo Southern, Nick Andrews, Clinical Infectious Diseases	2009	150
Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial David Goldblatt, Jo Southern, Nick Andrews, The Lancet Infectious Diseases	2017	126
Comparative Immunogenicity of 7 and 13-Valent Pneumococcal Conjugate Vaccines and the Development of Functional Antibodies to Cross-Reactive Serotypes Lindsay R. Grant, Sarah E. O’Brien, Polly Burbidge, PLoS ONE	2013	68
Immunogenicity of a Reduced Schedule of Pneumococcal Conjugate Vaccine in Healthy Infants and Correlates of Protection for Serotype 6B in the United Kingdom David Goldblatt, Jo Southern, Lindsey Ashton, The Pediatric Infectious Disease Journal	2010	68
Pneumococcal Conjugate Vaccine Given Shortly After Birth Stimulates Effective Antibody Concentrations and Primes Immunological Memory for Sustained Infant Protection J. Anthony G. Scott, John Ojal, Lindsey Ashton, Clinical Infectious Diseases	2011	60
Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study Laura L. Hammitt, Rosie J Crane, Angela Karani, The Lancet Global Health	2016	49
Pneumococcal Immune Response in Infants Whose Mothers Received Tetanus, Diphtheria and Acellular Pertussis Vaccination During Pregnancy Kirsten Maertens, Polly Burbidge, Pierre Van Damme, The Pediatric Infectious Disease Journal	2017	41

Page 1